First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study

被引：0
|
作者：
Hongzhong Liu
Qian Zhao
Yuping Yuan
Zhenlei Wang
Teng Wang
Wei Tian
Wen Zhong
Ji Jiang
Shuai Chen
Kai Kong
Chunyan Jin
Pei Hu
机构：
[1] Peking Union Medical College Hospital,Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigat
[2] Chinese Academy of Medical Sciences & Peking Union Medical College,Clinical Research Center for Innovative Drugs
[3] Tianjin Chasesun Pharmaceutical Co.,undefined
[4] Ltd.,undefined
来源：
Infectious Diseases and Therapy | 2024年 / 13卷
关键词：
Kukoamine B; Phase I trial; Pharmacokinetic; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：361 / 371
页数：10
相关论文
共 50 条
  • [21] Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design
    Min Wu
    Cuiyun Li
    Hong Zhang
    Jixuan Sun
    Xiaoxue Zhu
    Xiaojiao Li
    Xuedong Gao
    Wei Wang
    Yanhua Ding
    CNS Drugs, 2020, 34 : 867 - 877
  • [22] Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial
    Liu, Xiaoyan
    Zhang, Rui
    Li, Rong
    Wu, Qiong
    Pan, Chao
    Yu, Xiangqing
    Liu, Yuhui
    Wang, Benjie
    Yu, Shuwen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (12)
  • [23] Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study
    Yan, Xin
    Huang, Yuanyuan
    Xie, Jinlian
    Wu, Qian
    Yang, Shuang
    Yang, Xiaoyan
    Chen, Honghui
    Huang, Jie
    Yang, Guoping
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (07) : e0052424
  • [24] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    Taylor, Lesley
    Gidal, Barry
    Blakey, Graham
    Tayo, Bola
    Morrison, Gilmour
    CNS DRUGS, 2018, 32 (11) : 1053 - 1067
  • [25] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    Lesley Taylor
    Barry Gidal
    Graham Blakey
    Bola Tayo
    Gilmour Morrison
    CNS Drugs, 2018, 32 : 1053 - 1067
  • [26] A First-In-Human, Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ketamine in Healthy Volunteers
    Silman, Daniel
    Gadelrab, Romayne
    Qureshi, Mutahira
    Stein, Hans
    Mehta, Mitul
    Carmelline, Pietro
    Young, Allan
    Reilly, Carmel
    Duncan, Graeme
    Juruena, Mario
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 155 - 155
  • [27] Phase I, double-blind, placebo-controlled study in healthy male subjects to investigate the safety, tolerability, and pharmacokinetics of DA-8159
    Padma-Nathan, H
    Pacik, JS
    Ahn, BO
    Kang, KK
    Bahng, MY
    Kim, WB
    JOURNAL OF UROLOGY, 2004, 171 (04): : 234 - 234
  • [28] A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult Subjects
    Brager, Jenna
    Chapman, Chris
    Dunn, Leonard
    Kaplin, Adam
    DRUG RESEARCH, 2023, 73 (02) : 95 - 104
  • [29] Phase I, Randomized, Double-blind, Placebo-controlled, Single-dose, and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With Migraine
    de Hoon, Jan
    Van Hecken, Anne
    Vandermeulen, Corinne
    Yan, Lucy
    Smith, Brian
    Chen, Jiyun Sunny
    Bautista, Edgar
    Hamilton, Lisa
    Waksman, Javier
    Thuy Vu
    Vargas, Gabriel
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (05) : 815 - 825
  • [30] Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy SubjectsA Randomized, Double-Blind, Placebo-Controlled, Phase I Study
    Michael Derks
    Judith Anzures-Cabrera
    Lynn Turnbull
    Mary Phelan
    Clinical Drug Investigation, 2011, 31 : 325 - 335
12345